Your browser doesn't support javascript.
loading
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.
Yan, Victoria C; Pham, Cong-Dat; Ballato, Elliot S; Yang, Kristine L; Arthur, Kenisha; Khadka, Sunada; Barekatain, Yasaman; Shrestha, Prakriti; Tran, Theresa; Poral, Anton H; Washington, Mykia; Raghavan, Sudhir; Czako, Barbara; Pisaneschi, Federica; Lin, Yu-Hsi; Satani, Nikunj; Hammoudi, Naima; Ackroyd, Jeffrey J; Georgiou, Dimitra K; Millward, Steven W; Muller, Florian L.
Afiliación
  • Yan VC; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Pham CD; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Ballato ES; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Yang KL; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Arthur K; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Khadka S; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Barekatain Y; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Shrestha P; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Tran T; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Poral AH; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Washington M; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Raghavan S; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Czako B; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Pisaneschi F; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Lin YH; Institute of Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Satani N; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Hammoudi N; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Ackroyd JJ; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Georgiou DK; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Millward SW; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
  • Muller FL; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
J Med Chem ; 65(20): 13813-13832, 2022 10 27.
Article en En | MEDLINE | ID: mdl-36251833
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Glioblastoma / Organofosfonatos / Glioma Límite: Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Glioblastoma / Organofosfonatos / Glioma Límite: Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos